Asia's First Real-World ctDNA-MRD Study Strengthens Evidence for Cost-Effective Cancer Monitoring

Asia's First Real-World ctDNA-MRD Study Strengthens Evidence for Cost-Effective Cancer Monitoring

A landmark study recently published in March 2025 by JCO Oncology Advances, demonstrates the potential of K-TRACKTM in monitoring treatment response and assessing recurrence risk among 623 Solid-Tumor Patients of six cancer types (lung, colorectal,...

OCI GLOBAL CONFIRMS EURO EQUIVALENT DETAILS FOR Q2 2025 EXTRAORDINARY DISTRIBUTION

OCI GLOBAL CONFIRMS EURO EQUIVALENT DETAILS FOR Q2 2025 EXTRAORDINARY DISTRIBUTION

AMSTERDAM, April 16, 2025 /PRNewswire/ -- OCI Global (Euronext: OCI) ("OCI" or the "Company") today confirms that further to its announcement to pay an extraordinary cash distribution of USD 4.74 per share (USD 1.0 billion in total) on or around 7...

EDGNEX Data Centers by DAMAC Confirms Strategic Partnership with Nordic Data Center Developer Hyperco

EDGNEX Data Centers by DAMAC Confirms Strategic Partnership with Nordic Data Center Developer Hyperco

New acquisition in Nordics is part of the company's ambitious European and global expansion plan. The acquisition is expected to strengthen the expansion of the Hyperco brand further by adding significant growth capital to deliver significant future...

First NDIN-Completed Akkermansia muciniphila for Muscle Health: BiomeNrich™ POST M005

First NDIN-Completed Akkermansia muciniphila for Muscle Health: BiomeNrich™ POST M005

CHICAGO, March 26, 2025 /PRNewswire/ -- CJ BIO's BiomeNrich™ POST M005 is the first Akkermansia muciniphila-based ingredient to receive New Dietary Ingredient Notification (NDIN) acknowledgment from the U.S. Food and Drug Administration (FDA). This...

CES 2025 Audit Reveals Growing Attendance from Executives, Investors, and Media

CES 2025 Audit Reveals Growing Attendance from Executives, Investors, and Media

CES strengthens as the global convener of the tech ecosystem solving challenges and improving lives ARLINGTON, Va., March 27, 2025 /PRNewswire/ -- The Consumer Technology Association (CTA)® announces independently audited data for CES® 2025, the...

OMNICOM MEDIA GROUP AGENCY OMD TAKES TOP SLOT IN RECMA DIAGNOSTICS REPORT FOR NINTH CONSECUTIVE EDITION, REINFORCING ITS LEAD IN THE MARKETPLACE

OMNICOM MEDIA GROUP AGENCY OMD TAKES TOP SLOT IN RECMA DIAGNOSTICS REPORT FOR NINTH CONSECUTIVE EDITION, REINFORCING ITS LEAD IN THE MARKETPLACE

NEW YORK, March 21, 2025 /PRNewswire/ -- In the latest edition of the Network Diagnostics report from RECMA (Research Company Evaluating the Media Agency Industry), Omnicom Media Group agency OMD has been named the best performing global media...

Niutech's Tire Recycling Project Achieves International ISCC EU/PLUS Dual Certifications

Niutech's Tire Recycling Project Achieves International ISCC EU/PLUS Dual Certifications

JINAN, China, March 19, 2025 /PRNewswire/ -- International Sustainability and Carbon Certification (ISCC) is one of the most authoritative, valuable and influential green certificates in sustainability. It is the first standard that complies with...

New Recording From Jane Doe Confirms Shawn "JAY-Z" Carter Never Sexually Assaulted Her & Tony Buzbee Pushed Doe To Make False Claims

New Recording From Jane Doe Confirms Shawn "JAY-Z" Carter Never Sexually Assaulted Her & Tony Buzbee Pushed Doe To Make False Claims

NEW YORK, March 13, 2025 /PRNewswire/ -- Today, Shawn "JAY-Z" Carter's legal team announced that ABC News obtained and unveiled a new recording from Jane Doe that confirmed that Carter never sexually assaulted her and that lawyer Tony Buzbee urged...

World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection

World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection

Prospective study finds Lunit AI increases cancer detection by 13.8% in single-reader settings without raising recall rates, presenting a game-changing tool for countries relying on single-reader mammography screening SEOUL, South Korea, March 10,...

SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences.

SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences.

HIGHLIGHTS Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study. Based on the efficacy and safety assessment of all cohorts and the focus...

  • 1
  • 2
  • menu
    menu